Barclays PLC Atri Cure, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Barclays PLC holds 86,541 shares of ATRC stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,541

Previous 129,265 33.05%

Holding current value

$3.54 Million

Previous $3.63 Million 27.06%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$27.02 - $38.2 $1.15 Million - $1.63 Million	-42,724 Reduced 33.05%	86,541 $2.64 Million
Q3 2024 Nov 15, 2024	SELL	$20.34 - $29.5 $3.56 Million - $5.16 Million	-174,803 Reduced 57.49%	129,265 $3.63 Million
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $3.6 Million - $5.28 Million	181,492 Added 148.06%	304,068 $6.92 Million
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $1.16 Million - $1.56 Million	41,281 Added 50.78%	122,576 $3.73 Million
Q4 2023 Feb 15, 2024	BUY	$32.99 - $43.25 $2.03 Million - $2.66 Million	61,580 Added 312.35%	81,295 $2.9 Million
Q3 2023 Nov 07, 2023	SELL	$41.12 - $57.73 $43,134 - $60,558	-1,049 Reduced 5.05%	19,715 $864,000
Q2 2023 Aug 03, 2023	SELL	$40.44 - $49.6 $265,326 - $325,425	-6,561 Reduced 24.01%	20,764 $1.03 Million
Q1 2023 May 04, 2023	BUY	$35.87 - $47.22 $434,206 - $571,598	12,105 Added 79.53%	27,325 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$33.48 - $47.45 $334,297 - $473,788	9,985 Added 190.74%	15,220 $676,000
Q3 2022 Nov 03, 2022	SELL	$38.25 - $52.62 $80,478 - $110,712	-2,104 Reduced 28.67%	5,235 $205,000
Q2 2022 Aug 12, 2022	SELL	$35.1 - $66.01 $117,900 - $221,727	-3,359 Reduced 31.4%	7,339 $299,000
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $2.51 Million - $3.12 Million	-43,680 Reduced 80.33%	10,698 $703,000
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $1.42 Million - $1.95 Million	22,379 Added 69.94%	54,378 $3.78 Million
Q3 2021 Nov 09, 2021	BUY	$69.28 - $84.46 $1.23 Million - $1.5 Million	17,714 Added 124.0%	31,999 $2.23 Million
Q2 2021 Aug 13, 2021	SELL	$64.13 - $80.18 $4.38 Million - $5.48 Million	-68,293 Reduced 82.7%	14,285 $1.13 Million
Q1 2021 May 13, 2021	BUY	$53.79 - $66.98 $3.46 Million - $4.31 Million	64,417 Added 354.7%	82,578 $5.41 Million
Q4 2020 Feb 11, 2021	SELL	$34.56 - $57.55 $1.15 Million - $1.91 Million	-33,245 Reduced 64.67%	18,161 $1.01 Million
Q3 2020 Nov 12, 2020	SELL	$38.36 - $46.91 $239,443 - $292,812	-6,242 Reduced 10.83%	51,406 $2.05 Million
Q2 2020 Aug 12, 2020	SELL	$31.78 - $51.19 $5.2 Million - $8.38 Million	-163,731 Reduced 73.96%	57,648 $2.59 Million
Q1 2020 May 13, 2020	BUY	$24.49 - $43.84 $4.44 Million - $7.95 Million	181,367 Added 453.28%	221,379 $7.44 Million
Q4 2019 Feb 10, 2020	BUY	$24.06 - $32.51 $481,729 - $650,915	20,022 Added 100.16%	40,012 $1.3 Million
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $521,296 - $711,992	-21,894 Reduced 52.27%	19,990 $498,000
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $1.07 Million - $1.22 Million	-39,785 Reduced 48.71%	41,884 $1.25 Million
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $1.82 Million - $2.31 Million	69,172 Added 553.51%	81,669 $2.19 Million
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $265,187 - $346,652	-9,947 Reduced 44.32%	12,497 $383,000
Q3 2018 Nov 14, 2018	BUY	$27.62 - $35.58 $254,214 - $327,478	9,204 Added 69.52%	22,444 $786,000
Q2 2018 Aug 14, 2018	SELL	$19.65 - $30.28 $161,090 - $248,235	-8,198 Reduced 38.24%	13,240 $357,000
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $11,769 - $16,445	782 Added 3.79%	21,438 $440,000
Q4 2017 Feb 14, 2018	SELL	$17.69 - $23.44 $65,311 - $86,540	-3,692 Reduced 15.16%	20,656 $377,000
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $486,960 - $589,952	24,348	24,348 $545,000

Others Institutions Holding ATRC

# of Institutions

229

Shares Held

47.1M

Call Options Held

25.8K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.9B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account